JP2007510707A5 - - Google Patents

Download PDF

Info

Publication number
JP2007510707A5
JP2007510707A5 JP2006538974A JP2006538974A JP2007510707A5 JP 2007510707 A5 JP2007510707 A5 JP 2007510707A5 JP 2006538974 A JP2006538974 A JP 2006538974A JP 2006538974 A JP2006538974 A JP 2006538974A JP 2007510707 A5 JP2007510707 A5 JP 2007510707A5
Authority
JP
Japan
Prior art keywords
chlorophenyl
trifluoroethyl
triaza
compound
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006538974A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007510707A (ja
JP4056549B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2004/003522 external-priority patent/WO2005044822A1/en
Publication of JP2007510707A publication Critical patent/JP2007510707A/ja
Publication of JP2007510707A5 publication Critical patent/JP2007510707A5/ja
Application granted granted Critical
Publication of JP4056549B2 publication Critical patent/JP4056549B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006538974A 2003-11-07 2004-10-25 二環式ピラゾリルおよびイミダゾリル化合物ならびにその使用 Expired - Fee Related JP4056549B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51828003P 2003-11-07 2003-11-07
PCT/IB2004/003522 WO2005044822A1 (en) 2003-11-07 2004-10-25 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007183117A Division JP2007302685A (ja) 2003-11-07 2007-07-12 二環式ピラゾリルおよびイミダゾリル化合物ならびにその使用

Publications (3)

Publication Number Publication Date
JP2007510707A JP2007510707A (ja) 2007-04-26
JP2007510707A5 true JP2007510707A5 (https=) 2007-12-06
JP4056549B2 JP4056549B2 (ja) 2008-03-05

Family

ID=34572986

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006538974A Expired - Fee Related JP4056549B2 (ja) 2003-11-07 2004-10-25 二環式ピラゾリルおよびイミダゾリル化合物ならびにその使用
JP2007183117A Withdrawn JP2007302685A (ja) 2003-11-07 2007-07-12 二環式ピラゾリルおよびイミダゾリル化合物ならびにその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007183117A Withdrawn JP2007302685A (ja) 2003-11-07 2007-07-12 二環式ピラゾリルおよびイミダゾリル化合物ならびにその使用

Country Status (29)

Country Link
US (2) US7151097B2 (https=)
EP (1) EP1682554A1 (https=)
JP (2) JP4056549B2 (https=)
KR (1) KR20060086396A (https=)
CN (1) CN1886407A (https=)
AP (1) AP2006003601A0 (https=)
AR (1) AR046831A1 (https=)
AU (1) AU2004286909A1 (https=)
BR (1) BRPI0416299A (https=)
CA (1) CA2544752A1 (https=)
CR (1) CR8387A (https=)
DO (1) DOP2004001024A (https=)
EA (1) EA009742B1 (https=)
EC (1) ECSP066549A (https=)
GT (1) GT200400226A (https=)
HR (1) HRP20060166A2 (https=)
IL (1) IL175283A0 (https=)
IS (1) IS8426A (https=)
MA (1) MA28151A1 (https=)
MX (1) MXPA06005023A (https=)
NL (1) NL1027434C2 (https=)
NO (1) NO20062618L (https=)
OA (1) OA13280A (https=)
PA (1) PA8616801A1 (https=)
PE (1) PE20050576A1 (https=)
TN (1) TNSN06129A1 (https=)
TW (2) TW200716135A (https=)
WO (1) WO2005044822A1 (https=)
ZA (1) ZA200603594B (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
WO2004083388A2 (en) * 2003-03-14 2004-09-30 Bristol-Myers Squibb Company Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
US7151097B2 (en) * 2003-11-07 2006-12-19 Pfizer Inc. Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
ITMI20041032A1 (it) * 2004-05-24 2004-08-24 Neuroscienze S C A R L Compositi farmaceutici
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
US20060025448A1 (en) 2004-07-22 2006-02-02 Cadila Healthcare Limited Hair growth stimulators
WO2006035310A2 (en) * 2004-09-27 2006-04-06 Pfizer Products Inc. Process for preparing bicyclic pyrazolyl compounds
PA8660701A1 (es) 2005-02-04 2006-09-22 Pfizer Prod Inc Agonistas de pyy y sus usos
EP1874779A1 (en) * 2005-04-20 2008-01-09 Pfizer Products Inc. Acylaminobicyclic heteromatic compounds as cannabinoid receptor ligands
JP2008542255A (ja) * 2005-05-27 2008-11-27 ファイザー・プロダクツ・インク 肥満症の治療または体重減量の維持のためのカンナビノイド−1受容体アンタゴニストおよびミクロソームトリグリセリド輸送タンパク質阻害物質の併用
US8378117B2 (en) * 2005-09-23 2013-02-19 Janssen Pharmaceutica N.V. Hexahydro-cycloheptapyrazole cannabinoid modulators
US8378096B2 (en) * 2005-09-23 2013-02-19 Janssen Pharmaceutica N.V. Hexahydro-cycloheptapyrazole cannabinoid modulators
US7825151B2 (en) * 2005-09-23 2010-11-02 Janssen Pharmaceutica Nv Hexahydro-cyclooctyl pyrazole cannabinoid modulators
US7872006B2 (en) 2005-10-21 2011-01-18 Mitsubishi Tanabe Pharma Corporation Pyrazole compounds having cannabinoid receptor (CB1) antagonizing activity
WO2007060525A2 (en) 2005-11-28 2007-05-31 Pfizer Products Inc. Process for preparing bicyclic pyrazolyl and imidazolyl compounds
ES2402581T3 (es) * 2006-02-23 2013-05-06 Pfizer Limited Piperidinoilpirrolidinas como agonistas del receptor de melanocortina tipo 4
EP2742936A1 (en) * 2006-05-16 2014-06-18 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
WO2008048648A2 (en) * 2006-10-17 2008-04-24 Acadia Pharmaceuticals Inc. Cb1-modulating compounds and their use
MX2009004314A (es) 2006-11-13 2009-05-05 Pfizer Prod Inc Diaril, dipiridinil y arilpiridinilderivados y usos de los mismos.
US20090062253A1 (en) * 2007-08-31 2009-03-05 Kalypsys, Inc. Heterocyclodiazepine cannabinoid receptor modulators for treatment of disease
JP2010043063A (ja) 2008-05-09 2010-02-25 Agency For Science Technology & Research 川崎病の診断及び治療
JP5530438B2 (ja) * 2008-08-06 2014-06-25 ファイザー・リミテッド Mc4作動薬としてのジアゼピンおよびジアゾカン化合物
US9549006B2 (en) * 2013-07-31 2017-01-17 Cisco Technology, Inc. Self-adaptive sample period for content sharing in communication sessions
DK3066085T3 (da) * 2013-11-08 2020-06-02 Incyte Holdings Corp Fremgangsmåde til syntesen af en indolamin-2,3-dioxygenaseinhibitor
WO2020060761A2 (en) 2018-09-04 2020-03-26 Skodda Anja Pet food formulation with cannabinoids
US11504416B2 (en) 2018-09-04 2022-11-22 Paw Power, Inc. Formulation with cannabinoids
MY206471A (en) * 2019-08-09 2024-12-18 Nihon Nohyaku Co Ltd Oxazepinone derivative, agricultural/horticultural insecticide containing the same, and method for using the same

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001058869A2 (en) 2000-02-11 2001-08-16 Bristol-Myers Squibb Company Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
EP1421077A4 (en) 2001-08-31 2004-11-17 Univ Connecticut NEW PYRAZOLANALOGS ON CANNABINOID RECEPTORS
JP2005504100A (ja) 2001-09-24 2005-02-10 バイエル・フアーマシユーチカルズ・コーポレーシヨン 肥満の治療のための1,5,6,7−テトラヒドロピロロ[3,2−c]ピリジン誘導体の製造法および使用
GB0207249D0 (en) 2002-03-27 2002-05-08 Glaxo Group Ltd Novel compounds
AU2003267728A1 (en) 2002-10-18 2004-05-04 Pfizer Products Inc. Cannabinoid receptor ligands and uses thereof
US7129239B2 (en) 2002-10-28 2006-10-31 Pfizer Inc. Purine compounds and uses thereof
US7247628B2 (en) 2002-12-12 2007-07-24 Pfizer, Inc. Cannabinoid receptor ligands and uses thereof
US7329658B2 (en) 2003-02-06 2008-02-12 Pfizer Inc Cannabinoid receptor ligands and uses thereof
US7176210B2 (en) 2003-02-10 2007-02-13 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
US7145012B2 (en) 2003-04-23 2006-12-05 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
US20040214856A1 (en) 2003-04-23 2004-10-28 Pfizer Inc Cannabinoid receptor ligands and uses thereof
US7268133B2 (en) 2003-04-23 2007-09-11 Pfizer, Inc. Patent Department Cannabinoid receptor ligands and uses thereof
US7141669B2 (en) 2003-04-23 2006-11-28 Pfizer Inc. Cannabiniod receptor ligands and uses thereof
WO2004098520A2 (en) 2003-05-01 2004-11-18 Irm Llc Compounds and compositions as protein kinase inhibitors
JP4041153B2 (ja) 2003-05-07 2008-01-30 ファイザー・プロダクツ・インク カンナビノイド受容体リガンドとその使用
US7232823B2 (en) 2003-06-09 2007-06-19 Pfizer, Inc. Cannabinoid receptor ligands and uses thereof
US20040259887A1 (en) 2003-06-18 2004-12-23 Pfizer Inc Cannabinoid receptor ligands and uses thereof
US20050026983A1 (en) 2003-07-30 2005-02-03 Pfizer Inc Imidazole compounds and uses thereof
US7151097B2 (en) * 2003-11-07 2006-12-19 Pfizer Inc. Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
WO2006035310A2 (en) * 2004-09-27 2006-04-06 Pfizer Products Inc. Process for preparing bicyclic pyrazolyl compounds

Similar Documents

Publication Publication Date Title
JP2007510707A5 (https=)
DE60330800D1 (de) Verfahren zur herstellung von pyrrolotriazinverbindungen, die sich als kinaseinhibitoren eignen
Kumar et al. Mn (OAc) 3· 2H2O-mediated three-component, one-pot, condensation reaction: an efficient synthesis of 4-aryl-substituted 3, 4-dihydropyrimidin-2-ones
Kirichok et al. Synthesis of multifunctional spirocyclic azetidines and their application in drug discovery
NO20081941L (no) Pyrazol [1,5-alfa]pyrimidinylderivater nyttige som kortikotropin-frigivende faktor (CRF) reseptorantagonister
Kale et al. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons
CY2022009I1 (el) Διυδροναφθυριδινες και σχετικες ενωσεις χρησιμες ως αναστολεις κινασης για τη θεραπεια πολλαπλασιαστικων ασθενειων
CY1108378T1 (el) 4-υποκατεστημενα παραγωγα 1-αμινοκυκλοεξανιου για την χρησιμοποιηση σαν προσδεματα υποδοχεα orl1 ή οπιακου υποδοχεα mu
JP2006505581A5 (https=)
JP2001516732A5 (https=)
Matiychuk et al. 3-Aryl-2-chloropropanals in Hantzsch Synthesis of Pyrroles.
PE20081377A1 (es) Compuestos de tiazol pirazolopirimidina
ATE303366T1 (de) 4-amino-5-cyano-2-anilino-pyrimidin-derivate zur verwendung als inhibitoren von zellzyklus-kinasen
JP2005511547A5 (https=)
JP2005533804A5 (https=)
JP2006517220A5 (https=)
ATE447942T1 (de) Verfahren zur herstellung einer gegen missbrauch gesicherten darreichungsform
JP2009542721A5 (https=)
NO20055655L (no) Anvendelse av azetidinkarboksamidderivater i terapi
MX2024003925A (es) Terapia de combinación utilizando pirimidin-4(3h)-onas sustituidas y sotorasib
RU2006144710A (ru) Новые производные циклопента [b] бензофурана и их применение
JP2005521651A5 (https=)
Fedotov et al. Synthesis and properties of 6-(2, 6-dichlorophenyl)-3-(3-methyl-1H-pyrazol-5-yl)-6, 7-dihydro-5H-[1, 2, 4] triazolo [3, 4-b][1, 3, 4] thiadiazine-7-carboxylic acid and its salts
DE602004026333D1 (de) NEUE KRISTALLINE FORMEN VON ä2-Ä1-(3,5-BISTRIFLUORMETHYLBENZYL)-5-PYRIDIN-4-YL-1H-Ä1,2,3ÜÜTRIAZOL-4-YLÜ-PYRIDIN-3-YLü-(2-CHLORPHENYL)METHANON
JP2003513075A5 (https=)